Skip to main content
. Author manuscript; available in PMC: 2013 Dec 15.
Published in final edited form as: Pediatr Blood Cancer. 2012 Apr 5;59(7):1245–1251. doi: 10.1002/pbc.24152

Table I.

Patient characteristics of pediatric AMLs used in the present study.

Patient ID FAB Age (year) Sex Cytogenetics Blasts (%)
A30307 AML M6 10 Female 46, XX 29
A30308 AML M4/5 14 Male 46, XY, inv(16) 11
A30309 AML M4 0.8 Male 46, XY, inv(16) 30
A30310 AML M2 9 Male 46, XY 57
A30311 AML M4 14 Male 46, XY, t(3;5) 24
A30110 AML M5a 0.9 Male 46, XY, +9 73
A30207 AML M2 4.6 Male 46, XY, t(8;21) 82
A30224 AML M2 14.2 Female 46, XX, t(8;21) 48
A30230 AML M2 6.3 Female 46, XX, t(8;21) 39